img

Global Artemisinine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Artemisinine Market Insights, Forecast to 2034

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
Global Artemisinine market is expected to reach to US$ 64 million in 2024, with a positive growth of %, compared with US$ 62 million in 2022. Backed with the increasing demand from downstream industries, Artemisinine industry is evaluated to reach US$ 78 million in 2029. The CAGR will be 3.3% during 2024 to 2029.
Global Artemisinin key players include KPC Pharmaceuticals, Kerui nanhai, Sanofi, Guangxi xiancaotang, etc. Global top four manufacturers hold a share over 65%.
Europe is the largest market, with a share about 45%, followed by India, and Africa, both have a share about 40 percent.
In terms of product, Extraction from Artemisia annua is the largest segment, with a share over 82%. And in terms of application, the largest application is Antimalarial Tablets, followed by Antimalarial Injections.
Report Covers
This report presents an overview of global Artemisinine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Artemisinine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Guilin Pharmaceutical
CAT KHANH
Novanat Bioresource
BEEPZ
KPC Pharmaceuticals
BIONEXX
Guangxi xiancaotang
Sanofi
Natural Bio-engineering
Kerui nanhai
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinine

Segment by Application


Injections
Tablets
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Artemisinine plant distribution, commercial date of Artemisinine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Artemisinine introduction, etc. Artemisinine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Artemisinine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Artemisinine Product Introduction
1.2 Market by Type
1.2.1 Global Artemisinine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinine
1.3 Market by Application
1.3.1 Global Artemisinine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Injections
1.3.3 Tablets
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Artemisinine Sales Estimates and Forecasts 2018-2029
2.2 Global Artemisinine Revenue by Region
2.2.1 Global Artemisinine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Artemisinine Revenue by Region (2018-2024)
2.2.3 Global Artemisinine Revenue by Region (2024-2029)
2.2.4 Global Artemisinine Revenue Market Share by Region (2018-2029)
2.3 Global Artemisinine Sales Estimates and Forecasts 2018-2029
2.4 Global Artemisinine Sales by Region
2.4.1 Global Artemisinine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Artemisinine Sales by Region (2018-2024)
2.4.3 Global Artemisinine Sales by Region (2024-2029)
2.4.4 Global Artemisinine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Artemisinine Sales by Manufacturers
3.1.1 Global Artemisinine Sales by Manufacturers (2018-2024)
3.1.2 Global Artemisinine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Artemisinine in 2022
3.2 Global Artemisinine Revenue by Manufacturers
3.2.1 Global Artemisinine Revenue by Manufacturers (2018-2024)
3.2.2 Global Artemisinine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Artemisinine Revenue in 2022
3.3 Global Key Players of Artemisinine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Artemisinine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Artemisinine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Artemisinine, Product Offered and Application
3.8 Global Key Manufacturers of Artemisinine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Artemisinine Sales by Type
4.1.1 Global Artemisinine Historical Sales by Type (2018-2024)
4.1.2 Global Artemisinine Forecasted Sales by Type (2024-2029)
4.1.3 Global Artemisinine Sales Market Share by Type (2018-2029)
4.2 Global Artemisinine Revenue by Type
4.2.1 Global Artemisinine Historical Revenue by Type (2018-2024)
4.2.2 Global Artemisinine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Artemisinine Revenue Market Share by Type (2018-2029)
4.3 Global Artemisinine Price by Type
4.3.1 Global Artemisinine Price by Type (2018-2024)
4.3.2 Global Artemisinine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Artemisinine Sales by Application
5.1.1 Global Artemisinine Historical Sales by Application (2018-2024)
5.1.2 Global Artemisinine Forecasted Sales by Application (2024-2029)
5.1.3 Global Artemisinine Sales Market Share by Application (2018-2029)
5.2 Global Artemisinine Revenue by Application
5.2.1 Global Artemisinine Historical Revenue by Application (2018-2024)
5.2.2 Global Artemisinine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Artemisinine Revenue Market Share by Application (2018-2029)
5.3 Global Artemisinine Price by Application
5.3.1 Global Artemisinine Price by Application (2018-2024)
5.3.2 Global Artemisinine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Artemisinine Market Size by Type
6.1.1 US & Canada Artemisinine Sales by Type (2018-2029)
6.1.2 US & Canada Artemisinine Revenue by Type (2018-2029)
6.2 US & Canada Artemisinine Market Size by Application
6.2.1 US & Canada Artemisinine Sales by Application (2018-2029)
6.2.2 US & Canada Artemisinine Revenue by Application (2018-2029)
6.3 US & Canada Artemisinine Market Size by Country
6.3.1 US & Canada Artemisinine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Artemisinine Sales by Country (2018-2029)
6.3.3 US & Canada Artemisinine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Artemisinine Market Size by Type
7.1.1 Europe Artemisinine Sales by Type (2018-2029)
7.1.2 Europe Artemisinine Revenue by Type (2018-2029)
7.2 Europe Artemisinine Market Size by Application
7.2.1 Europe Artemisinine Sales by Application (2018-2029)
7.2.2 Europe Artemisinine Revenue by Application (2018-2029)
7.3 Europe Artemisinine Market Size by Country
7.3.1 Europe Artemisinine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Artemisinine Sales by Country (2018-2029)
7.3.3 Europe Artemisinine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Artemisinine Market Size
8.1.1 China Artemisinine Sales (2018-2029)
8.1.2 China Artemisinine Revenue (2018-2029)
8.2 China Artemisinine Market Size by Application
8.2.1 China Artemisinine Sales by Application (2018-2029)
8.2.2 China Artemisinine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artemisinine Market Size by Type
9.1.1 Asia Artemisinine Sales by Type (2018-2029)
9.1.2 Asia Artemisinine Revenue by Type (2018-2029)
9.2 Asia Artemisinine Market Size by Application
9.2.1 Asia Artemisinine Sales by Application (2018-2029)
9.2.2 Asia Artemisinine Revenue by Application (2018-2029)
9.3 Asia Artemisinine Sales by Region
9.3.1 Asia Artemisinine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Artemisinine Revenue by Region (2018-2029)
9.3.3 Asia Artemisinine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Artemisinine Market Size by Type
10.1.1 Middle East, Africa and Latin America Artemisinine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Artemisinine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Artemisinine Market Size by Application
10.2.1 Middle East, Africa and Latin America Artemisinine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Artemisinine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Artemisinine Sales by Country
10.3.1 Middle East, Africa and Latin America Artemisinine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Artemisinine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Artemisinine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Guilin Pharmaceutical
11.1.1 Guilin Pharmaceutical Company Information
11.1.2 Guilin Pharmaceutical Overview
11.1.3 Guilin Pharmaceutical Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Guilin Pharmaceutical Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Guilin Pharmaceutical Recent Developments
11.2 CAT KHANH
11.2.1 CAT KHANH Company Information
11.2.2 CAT KHANH Overview
11.2.3 CAT KHANH Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CAT KHANH Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CAT KHANH Recent Developments
11.3 Novanat Bioresource
11.3.1 Novanat Bioresource Company Information
11.3.2 Novanat Bioresource Overview
11.3.3 Novanat Bioresource Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Novanat Bioresource Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novanat Bioresource Recent Developments
11.4 BEEPZ
11.4.1 BEEPZ Company Information
11.4.2 BEEPZ Overview
11.4.3 BEEPZ Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 BEEPZ Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BEEPZ Recent Developments
11.5 KPC Pharmaceuticals
11.5.1 KPC Pharmaceuticals Company Information
11.5.2 KPC Pharmaceuticals Overview
11.5.3 KPC Pharmaceuticals Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 KPC Pharmaceuticals Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 KPC Pharmaceuticals Recent Developments
11.6 BIONEXX
11.6.1 BIONEXX Company Information
11.6.2 BIONEXX Overview
11.6.3 BIONEXX Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 BIONEXX Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BIONEXX Recent Developments
11.7 Guangxi xiancaotang
11.7.1 Guangxi xiancaotang Company Information
11.7.2 Guangxi xiancaotang Overview
11.7.3 Guangxi xiancaotang Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Guangxi xiancaotang Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Guangxi xiancaotang Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Overview
11.8.3 Sanofi Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Sanofi Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Sanofi Recent Developments
11.9 Natural Bio-engineering
11.9.1 Natural Bio-engineering Company Information
11.9.2 Natural Bio-engineering Overview
11.9.3 Natural Bio-engineering Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Natural Bio-engineering Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Natural Bio-engineering Recent Developments
11.10 Kerui nanhai
11.10.1 Kerui nanhai Company Information
11.10.2 Kerui nanhai Overview
11.10.3 Kerui nanhai Artemisinine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Kerui nanhai Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kerui nanhai Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Artemisinine Industry Chain Analysis
12.2 Artemisinine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Artemisinine Production Mode & Process
12.4 Artemisinine Sales and Marketing
12.4.1 Artemisinine Sales Channels
12.4.2 Artemisinine Distributors
12.5 Artemisinine Customers
13 Market Dynamics
13.1 Artemisinine Industry Trends
13.2 Artemisinine Market Drivers
13.3 Artemisinine Market Challenges
13.4 Artemisinine Market Restraints
14 Key Findings in The Global Artemisinine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Artemisinine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Extraction from Artemisia annua
Table 3. Major Manufacturers of Semisynthetic Artemisinine
Table 4. Global Artemisinine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Artemisinine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Artemisinine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Artemisinine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Artemisinine Revenue Market Share by Region (2018-2024)
Table 9. Global Artemisinine Revenue Market Share by Region (2024-2029)
Table 10. Global Artemisinine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Artemisinine Sales by Region (2018-2024) & (K Units)
Table 12. Global Artemisinine Sales by Region (2024-2029) & (K Units)
Table 13. Global Artemisinine Sales Market Share by Region (2018-2024)
Table 14. Global Artemisinine Sales Market Share by Region (2024-2029)
Table 15. Global Artemisinine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Artemisinine Sales Share by Manufacturers (2018-2024)
Table 17. Global Artemisinine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Artemisinine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Artemisinine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Artemisinine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Artemisinine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Artemisinine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artemisinine as of 2022)
Table 23. Global Key Manufacturers of Artemisinine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Artemisinine, Product Offered and Application
Table 25. Global Key Manufacturers of Artemisinine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Artemisinine Sales by Type (2018-2024) & (K Units)
Table 28. Global Artemisinine Sales by Type (2024-2029) & (K Units)
Table 29. Global Artemisinine Sales Share by Type (2018-2024)
Table 30. Global Artemisinine Sales Share by Type (2024-2029)
Table 31. Global Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Artemisinine Revenue Share by Type (2018-2024)
Table 34. Global Artemisinine Revenue Share by Type (2024-2029)
Table 35. Artemisinine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Artemisinine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Artemisinine Sales by Application (2018-2024) & (K Units)
Table 38. Global Artemisinine Sales by Application (2024-2029) & (K Units)
Table 39. Global Artemisinine Sales Share by Application (2018-2024)
Table 40. Global Artemisinine Sales Share by Application (2024-2029)
Table 41. Global Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Artemisinine Revenue Share by Application (2018-2024)
Table 44. Global Artemisinine Revenue Share by Application (2024-2029)
Table 45. Artemisinine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Artemisinine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Artemisinine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Artemisinine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Artemisinine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Artemisinine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Artemisinine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Artemisinine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Artemisinine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Artemisinine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Artemisinine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Artemisinine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Artemisinine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Artemisinine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Artemisinine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Artemisinine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Artemisinine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Artemisinine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Artemisinine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Artemisinine Sales by Country (2024-2029) & (K Units)
Table 73. China Artemisinine Sales by Type (2018-2024) & (K Units)
Table 74. China Artemisinine Sales by Type (2024-2029) & (K Units)
Table 75. China Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Artemisinine Sales by Application (2018-2024) & (K Units)
Table 78. China Artemisinine Sales by Application (2024-2029) & (K Units)
Table 79. China Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Artemisinine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Artemisinine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Artemisinine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Artemisinine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Artemisinine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Artemisinine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Artemisinine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Artemisinine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Artemisinine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Artemisinine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Artemisinine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Artemisinine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Artemisinine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Artemisinine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Artemisinine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Artemisinine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Artemisinine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Artemisinine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Artemisinine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Artemisinine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Artemisinine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Artemisinine Sales by Country (2024-2029) & (K Units)
Table 107. Guilin Pharmaceutical Company Information
Table 108. Guilin Pharmaceutical Description and Major Businesses
Table 109. Guilin Pharmaceutical Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Guilin Pharmaceutical Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Guilin Pharmaceutical Recent Developments
Table 112. CAT KHANH Company Information
Table 113. CAT KHANH Description and Major Businesses
Table 114. CAT KHANH Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. CAT KHANH Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CAT KHANH Recent Developments
Table 117. Novanat Bioresource Company Information
Table 118. Novanat Bioresource Description and Major Businesses
Table 119. Novanat Bioresource Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Novanat Bioresource Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Novanat Bioresource Recent Developments
Table 122. BEEPZ Company Information
Table 123. BEEPZ Description and Major Businesses
Table 124. BEEPZ Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. BEEPZ Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. BEEPZ Recent Developments
Table 127. KPC Pharmaceuticals Company Information
Table 128. KPC Pharmaceuticals Description and Major Businesses
Table 129. KPC Pharmaceuticals Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. KPC Pharmaceuticals Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. KPC Pharmaceuticals Recent Developments
Table 132. BIONEXX Company Information
Table 133. BIONEXX Description and Major Businesses
Table 134. BIONEXX Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. BIONEXX Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BIONEXX Recent Developments
Table 137. Guangxi xiancaotang Company Information
Table 138. Guangxi xiancaotang Description and Major Businesses
Table 139. Guangxi xiancaotang Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Guangxi xiancaotang Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Guangxi xiancaotang Recent Developments
Table 142. Sanofi Company Information
Table 143. Sanofi Description and Major Businesses
Table 144. Sanofi Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Sanofi Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Sanofi Recent Developments
Table 147. Natural Bio-engineering Company Information
Table 148. Natural Bio-engineering Description and Major Businesses
Table 149. Natural Bio-engineering Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Natural Bio-engineering Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Natural Bio-engineering Recent Developments
Table 152. Kerui nanhai Company Information
Table 153. Kerui nanhai Description and Major Businesses
Table 154. Kerui nanhai Artemisinine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Kerui nanhai Artemisinine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Kerui nanhai Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Artemisinine Distributors List
Table 160. Artemisinine Customers List
Table 161. Artemisinine Market Trends
Table 162. Artemisinine Market Drivers
Table 163. Artemisinine Market Challenges
Table 164. Artemisinine Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Artemisinine Product Picture
Figure 2. Global Artemisinine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Artemisinine Market Share by Type in 2022 & 2029
Figure 4. Extraction from Artemisia annua Product Picture
Figure 5. Semisynthetic Artemisinine Product Picture
Figure 6. Global Artemisinine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Artemisinine Market Share by Application in 2022 & 2029
Figure 8. Injections
Figure 9. Tablets
Figure 10. Others
Figure 11. Artemisinine Report Years Considered
Figure 12. Global Artemisinine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Artemisinine Revenue 2018-2029 (US$ Million)
Figure 14. Global Artemisinine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Artemisinine Revenue Market Share by Region (2018-2029)
Figure 16. Global Artemisinine Sales 2018-2029 ((K Units)
Figure 17. Global Artemisinine Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Artemisinine Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Artemisinine Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Artemisinine Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Artemisinine Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Artemisinine Sales YoY (2018-2029) & (K Units)
Figure 23. China Artemisinine Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Artemisinine Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Artemisinine Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Artemisinine Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Artemisinine Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Artemisinine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Artemisinine in the World: Market Share by Artemisinine Revenue in 2022
Figure 30. Global Artemisinine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Artemisinine Sales Market Share by Type (2018-2029)
Figure 32. Global Artemisinine Revenue Market Share by Type (2018-2029)
Figure 33. Global Artemisinine Sales Market Share by Application (2018-2029)
Figure 34. Global Artemisinine Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Artemisinine Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Artemisinine Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Artemisinine Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Artemisinine Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Artemisinine Revenue Share by Country (2018-2029)
Figure 40. US & Canada Artemisinine Sales Share by Country (2018-2029)
Figure 41. U.S. Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Artemisinine Sales Market Share by Type (2018-2029)
Figure 44. Europe Artemisinine Revenue Market Share by Type (2018-2029)
Figure 45. Europe Artemisinine Sales Market Share by Application (2018-2029)
Figure 46. Europe Artemisinine Revenue Market Share by Application (2018-2029)
Figure 47. Europe Artemisinine Revenue Share by Country (2018-2029)
Figure 48. Europe Artemisinine Sales Share by Country (2018-2029)
Figure 49. Germany Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 50. France Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 54. China Artemisinine Sales Market Share by Type (2018-2029)
Figure 55. China Artemisinine Revenue Market Share by Type (2018-2029)
Figure 56. China Artemisinine Sales Market Share by Application (2018-2029)
Figure 57. China Artemisinine Revenue Market Share by Application (2018-2029)
Figure 58. Asia Artemisinine Sales Market Share by Type (2018-2029)
Figure 59. Asia Artemisinine Revenue Market Share by Type (2018-2029)
Figure 60. Asia Artemisinine Sales Market Share by Application (2018-2029)
Figure 61. Asia Artemisinine Revenue Market Share by Application (2018-2029)
Figure 62. Asia Artemisinine Revenue Share by Region (2018-2029)
Figure 63. Asia Artemisinine Sales Share by Region (2018-2029)
Figure 64. Japan Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 68. India Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Artemisinine Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Artemisinine Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Artemisinine Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Artemisinine Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Artemisinine Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Artemisinine Sales Share by Country (2018-2029)
Figure 75. Brazil Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Artemisinine Revenue (2018-2029) & (US$ Million)
Figure 80. Artemisinine Value Chain
Figure 81. Artemisinine Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries